CARGO Therapeutics, Inc. (Nasdaq:CRGX)

Health Care/Life Sciences • Biotechnology

CIK 1966494

Company

Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.

Address
835 Industrial Road
Suite 400
San Carlos, California 94070

Employees
None

Stock Info

Close
$3.9200

Day Range
3.7500 - 3.9300

52 Week Range
3.0000 - 33.9200

Average volume
897.41K

Short Interest
3.31M (02/14/25)

% of Float Shorted
10.98%

Market Cap
$180.43M

Revenue
N/A

Net Income
N/A

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$3.5544

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

President, Chief Executive Officer & Director
Gina Chapman

Director
Jane Pritchett V. Henderson

Independent Director
Kapil Dhingra

Director
Abraham Bassan

Chairman
John A. Orwin

Independent Director
Krishnan Viswanadhan

Independent Director
David Charles Lubner

Independent Director
Reid M. Huber

SEC filings

Date	Form	Event
6 Dec, 2024	S-3ASR
15 Nov, 2024	4
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
14 Nov, 2024	SC 13G/A
13 Nov, 2024	424B3
12 Nov, 2024	8-K
12 Nov, 2024	10-Q
8 Nov, 2024	SC 13G
24 Oct, 2024	SC 13G
21 Oct, 2024	SC 13G/A
20 Sep, 2024	4
20 Sep, 2024	4
18 Sep, 2024	144
18 Sep, 2024	144
12 Aug, 2024	8-K
12 Aug, 2024	424B3
12 Aug, 2024	10-Q
8 Jul, 2024	8-K
27 Jun, 2024	424B3
27 Jun, 2024	EFFECT
25 Jun, 2024	CORRESP
25 Jun, 2024	UPLOAD
17 Jun, 2024	S-1
6 Jun, 2024	4
6 Jun, 2024	4
6 Jun, 2024	4
6 Jun, 2024	3
6 Jun, 2024	4
6 Jun, 2024	4
6 Jun, 2024	4
6 Jun, 2024	4
4 Jun, 2024	8-K
3 Jun, 2024	4
28 May, 2024	8-K
14 May, 2024	10-Q
14 May, 2024	8-K
24 Apr, 2024	DEFA14A
24 Apr, 2024	DEF 14A
17 Apr, 2024	3
17 Apr, 2024	4
15 Apr, 2024	8-K
22 Mar, 2024	S-8
21 Mar, 2024	10-K
21 Mar, 2024	8-K
8 Mar, 2024	8-K
4 Mar, 2024	4
4 Mar, 2024	4
4 Mar, 2024	4
4 Mar, 2024	4
14 Feb, 2024	SC 13G
14 Feb, 2024	SC 13G
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G
9 Feb, 2024	SC 13G/A
16 Jan, 2024	4
8 Jan, 2024	8-K
13 Dec, 2023	8-K
13 Dec, 2023	10-Q
11 Dec, 2023	SC 13G
24 Nov, 2023	SC 13G
24 Nov, 2023	3
21 Nov, 2023	SC 13G
21 Nov, 2023	SC 13G
20 Nov, 2023	SC 13G
16 Nov, 2023	4
16 Nov, 2023	4
15 Nov, 2023	S-8
14 Nov, 2023	4
14 Nov, 2023	8-K
14 Nov, 2023	SC 13G
14 Nov, 2023	4
13 Nov, 2023	4
13 Nov, 2023	4
13 Nov, 2023	424B4	IPO completed
13 Nov, 2023	4
13 Nov, 2023	4
13 Nov, 2023	4
13 Nov, 2023	4
13 Nov, 2023	3
9 Nov, 2023	3
9 Nov, 2023	3
9 Nov, 2023	3
9 Nov, 2023	3
9 Nov, 2023	3
9 Nov, 2023	CERT
9 Nov, 2023	SEC STAFF
9 Nov, 2023	3
9 Nov, 2023	3
9 Nov, 2023	EFFECT
9 Nov, 2023	3
9 Nov, 2023	3
9 Nov, 2023	3
9 Nov, 2023	3
9 Nov, 2023	3
7 Nov, 2023	8-A12B
7 Nov, 2023	CORRESP
7 Nov, 2023	CORRESP
6 Nov, 2023	S-1/A
1 Nov, 2023	S-1/A
30 Oct, 2023	CORRESP
24 Oct, 2023	SEC STAFF
20 Oct, 2023	CORRESP
20 Oct, 2023	S-1
12 Oct, 2023	UPLOAD
4 Oct, 2023	DRSLTR
4 Oct, 2023	DRS/A
28 Sep, 2023	UPLOAD
1 Sep, 2023	DRS
1 Mar, 2023	D

Last update:2025-03-06 12:14:18.882951

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.